ARCHIVES

Campath Improves PFS In B-Cell CLL In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

Studies Are Demonstrating Effectiveness of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 5, 1974

First Lady Helps Dedicate New MDA Facilities

October 15, 1976

NCI Conducting Four Epidemiology Studies On Radon

July 1, 1988

NCAB Discussion Of Working Group Report

February 28, 2003

UC Davis Is U.S. Site For Trial Of Exemestane For Breast Ca.

September 24, 2004

Von Eschenbach Says He Will Step Down as NCI Director; No Acting Director Has Been Named.

March 24, 2006